A detailed history of Tweedy Browne Co. (Tweedy, Browne CO LLC) transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Tweedy, Browne CO LLC holds 54,346 shares of VRTX stock, worth $26.8 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
54,346
Previous 66,699 18.52%
Holding current value
$26.8 Million
Previous $27.9 Million 8.63%
% of portfolio
1.2%
Previous 1.35%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$392.81 - $485.53 $4.85 Million - $6 Million
-12,353 Reduced 18.52%
54,346 $25.5 Million
Q1 2024

May 06, 2024

SELL
$407.69 - $446.08 $26,499 - $28,995
-65 Reduced 0.1%
66,699 $27.9 Million
Q4 2023

Feb 13, 2024

SELL
$343.0 - $410.68 $2.83 Million - $3.38 Million
-8,240 Reduced 10.99%
66,764 $27.2 Million
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $25.4 Million - $27.2 Million
75,004 New
75,004 $26.1 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $127B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track Tweedy Browne Co.'s Portfolio

Track Tweedy Browne Co. Portfolio

Follow Tweedy Browne Co. (Tweedy, Browne CO LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tweedy, Browne CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tweedy, Browne CO LLC and Tweedy Browne Co. with notifications on news.